Breaking News Instant updates and real-time market news.

ALKS

Alkermes

$18.86

0.44 (2.39%)

15:59
10/23/19
10/23
15:59
10/23/19
15:59

Alkermes price target lowered to $23 from $25 at Stifel

Stifel analyst Paul Matteis lowered his price target for Alkermes to $23 from $25 and reiterates a Hold rating on the shares. The Q3 results were a "mixed bag," as the misses for Aristada and Vivitrol were balanced by the restructuring announcement, Matteis tells investors in a post-earnings research note. Investors will be happy to see some cost discipline from Alkermes, as the company's margin expansion story "hasn't played out as well as some investors had hoped," adds the analyst. Matteis reduced some of his long-term Vivitrol and Aristada projections.

  • 23

    Oct

  • 06

    Nov

ALKS Alkermes
$18.86

0.44 (2.39%)

07/30/19
JPMS
07/30/19
NO CHANGE
JPMS
Overweight
Alkermes, Biogen data a positive, but questions remain, says JPMorgan
JPMorgan analyst Cory Kasimov views the data this morning from Alkermes (ALKS) and Biogen (BIIB) as an incremental positive but he believes commercial questions remain for Vumerity. The analyst has an Overweight rating on Alkermes and Neutral rating on Biogen. How doctors will view this dataset and how aggressive Biogen will be in launching Vumerity in the face of questions regarding Tecfidera's ultimate runway are the next key questions, Kasimov tells investors in a research note. However, he calls this morning's news a "good-to-see outcome."
07/30/19
PIPR
07/30/19
NO CHANGE
PIPR
Neutral
Piper says Alkermes scores 'back-to-back wins' with settlement, Biogen data
Piper Jaffray analyst Danielle Brill said Alkermes (ALKS) has scored "back-to-back wins" with its announcement yesterday that it settled the ongoing Vivitrol patent dispute with Amneal (AMRX) and the news this morning that BIIB098 showed a statistically significant improvement on GI tolerability versus Tecfidera in a head-to-head Phase 3 trial. She still questions how meaningful the improvement in GI tolerability actually is, but thinks the drug may become a priority for partner Biogen (BIIB), Brill tells investors. The analyst, who views the news of the last two days as net positive for Alkermes, maintains her concerns about long-term value creation and the company's "dry pipeline," she said. Brill keeps a Neutral rating on Alkermes shares.
09/05/19
MSCO
09/05/19
UPGRADE
Target $20
MSCO
Equal Weight
Alkermes upgraded to Equal Weight from Underweight at Morgan Stanley
Morgan Stanley analyst David Risinger upgraded Alkermes to Equal Weight from Underweight while lowering his price target for the shares to $20 from $30. The stock has underperformed, and recent developments eliminated the worst-case scenarios for Vumerity trial results and Vivitrol's patent, Risinger tells investors in a research note. Although cancer pipeline candidate ALKS 4230 could still disappoint, consensus expectations are low due to a questionable profile, adds the analyst. He believes Alkermes' long-term risk to royalty streams is balanced by its pipeline or cost savings optionality at current share levels.
10/23/19
PIPR
10/23/19
NO CHANGE
Target $22
PIPR
Neutral
Alkermes making some positive changes, says Piper Jaffray
Piper Jaffray analyst Danielle Brill said she believes Alkermes "is making some positive changes" with its restructuring plans, adding that the company's need for pipeline growth was reinforced by "another disappointing revision" to its outlook for Aristada revenue. In Q3, Aristada's slower than anticipated growth was offset by higher than anticipated Sustenna royalties, helping the company to beat revenue expectations and maintain its FY19 guidance, Brill noted. She doubts that the company's Vumerity and 3831 opportunities will offset upcoming royalty expirations, leading her to keep a Neutral rating on the stock, but Brill added that she could get more constructive on Alkermes if it makes promising pipeline additions.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$294.17

5.51 (1.91%)

12:33
11/22/19
11/22
12:33
11/22/19
12:33
Periodicals
Breaking Periodicals news story on Biogen »

Biogen settles Tecfidera…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 05

    Dec

BIIB

Biogen

$293.68

5.02 (1.74%)

12:26
11/22/19
11/22
12:26
11/22/19
12:26
Hot Stocks
Breaking Hot Stocks news story on Biogen »

Biogen rallies 3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 05

    Dec

FTCH

Farfetch

$9.73

0.335 (3.57%)

12:25
11/22/19
11/22
12:25
11/22/19
12:25
Options
Farfetch Limited call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$310.63

0.34 (0.11%)

12:18
11/22/19
11/22
12:18
11/22/19
12:18
General news
Ray Dalio says WSJ wrong, Bridgewater not betting market will fall »

Ray Dalio, Co-Chief…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$310.63

0.34 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/22/19
11/22
12:17
11/22/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/22/19
11/22
12:16
11/22/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DELL

Dell Technologies

$53.30

-0.425 (-0.79%)

12:15
11/22/19
11/22
12:15
11/22/19
12:15
Options
Dell Technologies put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 02

    Dec

  • 09

    Dec

  • 09

    Dec

12:15
11/22/19
11/22
12:15
11/22/19
12:15
General news
Treasury Action: the markets are mixed with no strong directional drivers »

Treasury Action: the…

RF

Regions Financial

$16.68

0.19 (1.15%)

12:05
11/22/19
11/22
12:05
11/22/19
12:05
Options
Regions Financial call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

SPCE

Virgin Galactic

$7.57

-0.88 (-10.41%)

12:00
11/22/19
11/22
12:00
11/22/19
12:00
Hot Stocks
Virgin Galactic falls -10.3% »

Virgin Galactic is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

PSTG

Pure Storage

$16.24

-3.6 (-18.15%)

12:00
11/22/19
11/22
12:00
11/22/19
12:00
Hot Stocks
Pure Storage falls -18.2% »

Pure Storage is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 09

    Dec

  • 12

    Dec

  • 10

    Mar

  • 11

    Mar

DAC

Danaos

$5.65

-1.68 (-22.92%)

12:00
11/22/19
11/22
12:00
11/22/19
12:00
Hot Stocks
Danaos falls -26.2% »

Danaos is down -26.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

GSX

GSX Techedu

$18.88

2.625 (16.15%)

12:00
11/22/19
11/22
12:00
11/22/19
12:00
Hot Stocks
GSX Techedu rises 16.5% »

GSX Techedu is up 16.5%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BKE

The Buckle

$26.24

3.9 (17.46%)

12:00
11/22/19
11/22
12:00
11/22/19
12:00
Hot Stocks
The Buckle rises 17.4% »

The Buckle is up 17.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

SSI

Stage Stores

$4.30

0.95 (28.36%)

12:00
11/22/19
11/22
12:00
11/22/19
12:00
Hot Stocks
Stage Stores rises 27.7% »

Stage Stores is up 27.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$219.83

1.6 (0.73%)

, JPM

JPMorgan

$130.91

0.95 (0.73%)

11:57
11/22/19
11/22
11:57
11/22/19
11:57
On The Fly
Fly Intel: Wall Street's top stories at midday »

Markets were mixed near…

GS

Goldman Sachs

$219.83

1.6 (0.73%)

JPM

JPMorgan

$130.91

0.95 (0.73%)

TSLA

Tesla

$332.94

-21.88 (-6.17%)

F

Ford

$8.84

0.115 (1.32%)

GM

General Motors

$35.30

0.64 (1.85%)

GPS

Gap

$16.69

0.47 (2.90%)

UBER

Uber

$29.59

0.13 (0.44%)

HIBB

Hibbett Sports

$29.00

3.93 (15.68%)

JWN

Nordstrom

$37.50

3.21 (9.36%)

SPLK

Splunk

$135.96

9.16 (7.22%)

PSTG

Pure Storage

$16.26

-3.58 (-18.04%)

FL

Foot Locker

$39.54

-1.92 (-4.63%)

WSM

Williams-Sonoma

$66.86

-1.9 (-2.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 22

    Nov

  • 02

    Dec

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

  • 14

    Jan

  • 15

    Jan

  • 04

    Feb

  • 10

    Mar

  • 11

    Mar

ACM

Aecom

$42.48

0.095 (0.22%)

11:55
11/22/19
11/22
11:55
11/22/19
11:55
Conference/Events
Aecom participates in a conference call with BofA/Merrill »

Aecom discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 10

    Dec

DE

Deere

$176.24

0.18 (0.10%)

11:46
11/22/19
11/22
11:46
11/22/19
11:46
Conference/Events
Deutsche Bank machinery analysts to hold an analyst/industry conference call »

Machinery Analysts, along…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 03

    Dec

HIIQ

Health Insurance Innovations

$16.15

-0.85 (-5.00%)

11:45
11/22/19
11/22
11:45
11/22/19
11:45
Options
Health Insurance Innovations call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBI

Hanesbrands

$14.93

0.16 (1.08%)

11:35
11/22/19
11/22
11:35
11/22/19
11:35
Options
HanesBrands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$197.95

-0.15 (-0.08%)

11:34
11/22/19
11/22
11:34
11/22/19
11:34
Periodicals
Facebook to turn over additional docs in California privacy probe, Reuters says »

Facebook has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

BA

Boeing

$368.13

1.66 (0.45%)

11:31
11/22/19
11/22
11:31
11/22/19
11:31
Hot Stocks
Boeing says SVP of Communications Anne Toulouse to step down at year-end »

Boeing announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZTCOY

ZTE Corp.

$0.00

(0.00%)

, MU

Micron

$46.10

0.56 (1.23%)

11:30
11/22/19
11/22
11:30
11/22/19
11:30
Periodicals
Breaking Periodicals news story on ZTE Corp., Micron, Western Digital, Bought by LITE, Acacia Communications, NeoPhotonics, Lumentum, II-VI »

FCC declares Huawei, ZTE…

ZTCOY

ZTE Corp.

$0.00

(0.00%)

MU

Micron

$46.10

0.56 (1.23%)

WDC

Western Digital

$48.44

0.59 (1.23%)

OCLR

Bought by LITE

$0.00

(0.00%)

ACIA

Acacia Communications

$66.67

-0.02 (-0.03%)

NPTN

NeoPhotonics

$8.08

-0.11 (-1.34%)

LITE

Lumentum

$67.67

0.54 (0.80%)

IIVI

II-VI

$27.35

-0.11 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 03

    Dec

  • 09

    Dec

  • 09

    Dec

  • 18

    Dec

GOOG

Alphabet

$1,296.07

-5.13 (-0.39%)

, GOOGL

Alphabet Class A

$1,294.89

-4.86 (-0.37%)

11:28
11/22/19
11/22
11:28
11/22/19
11:28
Periodicals
Google denies reports claiming Stadia units experiencing overheating, Vice says »

Some Google Stadia…

GOOG

Alphabet

$1,296.07

-5.13 (-0.39%)

GOOGL

Alphabet Class A

$1,294.89

-4.86 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$16.44

0.2 (1.23%)

11:25
11/22/19
11/22
11:25
11/22/19
11:25
Options
Chemours call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.